Comments
Target: ₹6,978
CMP: ₹6,615.80
In Q3-FY24, Apollo Hospitals Enterprise Limited (APHS) reported a good set of performance which outperformed our expectations on all fronts. Revenue for the quarter grew by 13.8 per cent y-o-y and flat sequentially to ₹4,850 crore. EBITDA grew by 21.4 per cent y-o-y however down by 2.2 per cent q-o-q to ₹613 crore. The EBITDA margin expanded by 80 bps y-o-y and contracted sequentially by 29 bps to 12.7 per cent. The ARPOB saw a double-digit growth despite seasonal tailwinds and Chennai cyclones. ARPOB stood at ₹56,328 per day, up 10 per cent y-o-y.
Overall hospital occupancy increased to 65 per cent, compared to 64 per cent in the same period the previous year, supported by a robust increase in patient flows.
The positive outlook on AHEL is upheld based on several factors, including an aggressive store expansion plan, a comprehensive presence in the healthcare delivery chain, ongoing cost optimisation measures, and an increase in occupancy levels. However, adjustments to margin expectations have been made, considering a longer-than-expected timeline for the improvement in operations for healthcare and diagnostic centers.
The stock is valued through a SOTP analysis, resulting in a price target of ₹6,978. The rating is maintained at ADD.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.